Solid Biosciences Inc. - 10-Q Filing

Solid Biosciences Inc. filed its quarterly report for the period ended March 31, 2026, providing updates on financial and operational activities including research and development expenses related to SGT-212 and other programs.

SEC EDGAR ·

Tickers: $SLDB

Read the full article at SEC EDGAR

More Regulatory news